MGMT and neoplasm: GBM is also an inherently heterogeneous tumor and one study looked at changes in MGMT promoter methylation status, dividing the study into three groups: methylated, unmethylated, and methylated to unmethylated, and observed that methylation status changed in recurrent GBMs after standard treatment [76].